Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Effectiveness of G8 and VES-13 Frailty Scales in Predicting Chemotherapy Toxicity in Older Patients With Gastrointestinal Cancers: A Prospective Observational Study

NCT07184047 is registered in ClinicalTrials.gov with Ankara Etlik City Hospital as lead sponsor.

NCT NCT07184047
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07184047 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Effectiveness of G8 and VES-13 Frailty Scales in Predicting Chemotherapy Toxicity in Older Patients With Gastrointestinal Cancers: A Prospective Observational Study
Lead sponsor
Ankara Etlik City Hospital
Phase
Observational
Overall status
Completed
Start date
January 15, 2024
Completion date
February 19, 2026
Enrollment
72 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

biliary tract cancer, colorectal cancer, esophageal cancer (esc), frailty, gastric cancer (gc), gastrointestinal cancers, malnutrition elderly, older adults (65 years and older), pancreatic cancer resectable, sarcopenia in elderly, toxicity due to chemotherapy